Right now the company is in partnership discussions to further develop Brilacidin for local treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis. IBD is a huge world wide market. Hopefully IPIX can make a difference as they advance their pill form.
Market Data 
Markets 
AI
